Early Clinical Outcomes following Lecanemab Therapy for Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s Disease (S23.002)

Authors

Arjun V. Masurkar (ORCID: https://orcid.org/0000-0002-2498-2059)
Kristen Watkins
Thomas Wısnıewskı (ORCID: https://orcid.org/0000-0002-3379-8966)
Joel Salinas (ORCID: https://orcid.org/0000-0002-3735-0018)
Martin C. Sadowski
Jack W. Tsao (ORCID: https://orcid.org/0000-0002-7425-8763)
Philip Kuball
Isabel Stobin

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000212315
Primary Topic: Cancer-related cognitive impairment studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Early Clinical Outcomes following Lecanemab Therapy for Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s Disease (S23.002)

Arjun V. Masurkar, Kristen Watkins, Thomas Wısnıewskı, Joel Salinas et al.

Apr 7, 2025

Neurology

Cancer-related cognitive impairment studies

article

Early Clinical Outcomes following Lecanemab Therapy for Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s Disease (S23.002)

Arjun V. Masurkar, Kristen Watkins, Thomas Wısnıewskı, Joel Salinas, Martin C. Sadowski, Jack W. Tsao, Philip Kuball, Isabel Stobin

April 7, 2025article en

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Openalex Percentile: Top 89%

Cancer-related cognitive impairment studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Early Clinical Outcomes following Lecanemab Therapy for Mild Cognitive Impairment and Mild Dementia due to Alzheimer’s Disease (S23.002) — Arjun V. Masurkar, Kristen Watkins, et al. · Neurology (2025) | TGRS Research Map | TGRS